Search by Drug Name or NDC

    NDC 62332-0042-71 IRBESARTAN 150 mg/1 Details

    IRBESARTAN 150 mg/1

    IRBESARTAN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is IRBESARTAN.

    Product Information

    NDC 62332-0042
    Product ID 62332-042_ca735540-a911-4890-814d-a9b8d3d87bfc
    Associated GPIs 36150030000320
    GCN Sequence Number 034468
    GCN Sequence Number Description irbesartan TABLET 150 MG ORAL
    HIC3 A4F
    HIC3 Description ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST
    GCN 04749
    HICL Sequence Number 015576
    HICL Sequence Number Description IRBESARTAN
    Brand/Generic Generic
    Proprietary Name IRBESARTAN
    Proprietary Name Suffix n/a
    Non-Proprietary Name IRBESARTAN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name IRBESARTAN
    Labeler Name Alembic Pharmaceuticals Inc.
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091236
    Listing Certified Through 2024-12-31

    Package

    NDC 62332-0042-71 (62332004271)

    NDC Package Code 62332-042-71
    Billing NDC 62332004271
    Package 500 TABLET in 1 BOTTLE (62332-042-71)
    Marketing Start Date 2016-07-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.17106
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description IRBESARTAN 150 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 83f5d5c8-27c0-4208-a291-0c4aa55a1ff5 Details

    Revised: 12/2021